Literature DB >> 30854500

Development of a Fully Cross-Validated Bayesian Network Approach for Local Control Prediction in Lung Cancer.

Yi Luo1, Daniel McShan2, Dipankar Ray2, Martha Matuszak2, Shruti Jolly2, Theodore Lawrence2, Feng Ming Kong3, Randall Ten Haken2, Issam El Naqa2.   

Abstract

The purpose of this study is to demonstrate that a Bayesian network (BN) approach can explore hierarchical biophysical relationships that influence tumor response and predict tumor local control (LC) in non-small-cell lung cancer (NSCLC) patients before and during radiotherapy from a large-scale dataset. Our BN building approach has two steps. First, relevant biophysical predictors influencing LC before and during the treatment are selected through an extended Markov blanket (eMB) method. From this eMB process, the most robust BN structure for LC prediction was found via a wrapper-based approach. Sixty-eight patients with complete feature information were used to identify a full BN model for LC prediction before and during the treatment. Fifty more recent patients with some missing information were reserved for independent testing of the developed pre- and during-therapy BNs. A nested cross-validation (N-CV) was developed to evaluate the performance of the two-step BN approach. An ensemble BN model is generated from the N-CV sampling process to assess its similarity with the corresponding full BN model, and thus evaluate the sensitivity of our BN approach. Our results show that the proposed BN development approach is a stable and robust approach to identify hierarchical relationships among biophysical features for LC prediction. Furthermore, BN predictions can be improved by incorporating during treatment information.

Entities:  

Keywords:  Bayesian networks; large-scale model building; local control prediction; non–small-cell lung cancer; pan-Omics

Year:  2018        PMID: 30854500      PMCID: PMC6404542          DOI: 10.1109/TRPMS.2018.2832609

Source DB:  PubMed          Journal:  IEEE Trans Radiat Plasma Med Sci        ISSN: 2469-7303


  52 in total

1.  Prognostic factors for local control in non-small-cell lung cancer treated with definitive radiation therapy.

Authors:  Ming Chen; Guo-Liang Jiang; Xiao-Long Fu; Li-Juan Wang; Hao Qian; Sen Zhao; Tai-Fu Liu
Journal:  Am J Clin Oncol       Date:  2002-02       Impact factor: 2.339

2.  Association of DNA repair and steroid metabolism gene polymorphisms with clinical late toxicity in patients treated with conformal radiotherapy for prostate cancer.

Authors:  Sambasivarao Damaraju; David Murray; Jennifer Dufour; Diana Carandang; Sten Myrehaug; Gino Fallone; Colin Field; Russell Greiner; John Hanson; Carol E Cass; Matthew Parliament
Journal:  Clin Cancer Res       Date:  2006-04-15       Impact factor: 12.531

Review 3.  Chemokines and cancer.

Authors:  A Zlotnik
Journal:  Ernst Schering Res Found Workshop       Date:  2004

4.  HITON: a novel Markov Blanket algorithm for optimal variable selection.

Authors:  C F Aliferis; I Tsamardinos; A Statnikov
Journal:  AMIA Annu Symp Proc       Date:  2003

5.  Causal protein-signaling networks derived from multiparameter single-cell data.

Authors:  Karen Sachs; Omar Perez; Dana Pe'er; Douglas A Lauffenburger; Garry P Nolan
Journal:  Science       Date:  2005-04-22       Impact factor: 47.728

Review 6.  Chemokines and cancer.

Authors:  Thomas T Murooka; Sarah E Ward; Eleanor N Fish
Journal:  Cancer Treat Res       Date:  2005

7.  Predicting the prognosis of breast cancer by integrating clinical and microarray data with Bayesian networks.

Authors:  Olivier Gevaert; Frank De Smet; Dirk Timmerman; Yves Moreau; Bart De Moor
Journal:  Bioinformatics       Date:  2006-07-15       Impact factor: 6.937

8.  High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: long-term results of a radiation dose escalation study.

Authors:  Feng-Ming Kong; Randall K Ten Haken; Matthew J Schipper; Molly A Sullivan; Ming Chen; Carlos Lopez; Gregory P Kalemkerian; James A Hayman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-10-01       Impact factor: 7.038

9.  c-Myc-regulated microRNAs modulate E2F1 expression.

Authors:  Kathryn A O'Donnell; Erik A Wentzel; Karen I Zeller; Chi V Dang; Joshua T Mendell
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

10.  Polymorphisms in immunoregulatory genes, smoky coal exposure and lung cancer risk in Xuan Wei, China.

Authors:  Kyoung-Mu Lee; Min Shen; Robert S Chapman; Meredith Yeager; Robert Welch; Xingzhou He; Tongzhang Zheng; H Dean Hosgood; Dongyun Yang; Sonja I Berndt; Stephen Chanock; Qing Lan
Journal:  Carcinogenesis       Date:  2007-03-14       Impact factor: 4.944

View more
  16 in total

1.  A multiobjective Bayesian networks approach for joint prediction of tumor local control and radiation pneumonitis in nonsmall-cell lung cancer (NSCLC) for response-adapted radiotherapy.

Authors:  Yi Luo; Daniel L McShan; Martha M Matuszak; Dipankar Ray; Theodore S Lawrence; Shruti Jolly; Feng-Ming Kong; Randall K Ten Haken; Issam El Naqa
Journal:  Med Phys       Date:  2018-06-04       Impact factor: 4.071

2.  Markerless Pancreatic Tumor Target Localization Enabled By Deep Learning.

Authors:  Wei Zhao; Liyue Shen; Bin Han; Yong Yang; Kai Cheng; Diego A S Toesca; Albert C Koong; Daniel T Chang; Lei Xing
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-06-13       Impact factor: 7.038

3.  Predictive Modeling of Survival and Toxicity in Patients With Hepatocellular Carcinoma After Radiotherapy.

Authors:  Ibrahim Chamseddine; Yejin Kim; Brian De; Issam El Naqa; Dan G Duda; John Wolfgang; Jennifer Pursley; Harald Paganetti; Jennifer Wo; Theodore Hong; Eugene J Koay; Clemens Grassberger
Journal:  JCO Clin Cancer Inform       Date:  2022-02

4.  Radiation Therapy Outcomes Models in the Era of Radiomics and Radiogenomics: Uncertainties and Validation.

Authors:  Issam El Naqa; Gaurav Pandey; Hugo Aerts; Jen-Tzung Chien; Christian Nicolaj Andreassen; Andrzej Niemierko; Randall K Ten Haken
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-10-18       Impact factor: 7.038

Review 5.  Artificial Intelligence for Response Evaluation With PET/CT.

Authors:  Lise Wei; Issam El Naqa
Journal:  Semin Nucl Med       Date:  2020-11-11       Impact factor: 4.446

6.  Simulation of Logistics Delay in Bayesian Network Control Based on Genetic EM Algorithm.

Authors:  Pengliang Qiao
Journal:  Comput Intell Neurosci       Date:  2022-04-07

Review 7.  Radiomics in radiation oncology-basics, methods, and limitations.

Authors:  Philipp Lohmann; Khaled Bousabarah; Mauritius Hoevels; Harald Treuer
Journal:  Strahlenther Onkol       Date:  2020-07-09       Impact factor: 3.621

Review 8.  Machine and deep learning methods for radiomics.

Authors:  Michele Avanzo; Lise Wei; Joseph Stancanello; Martin Vallières; Arvind Rao; Olivier Morin; Sarah A Mattonen; Issam El Naqa
Journal:  Med Phys       Date:  2020-06       Impact factor: 4.071

Review 9.  Value of PET imaging for radiation therapy.

Authors:  Constantin Lapa; Ursula Nestle; Nathalie L Albert; Christian Baues; Ambros Beer; Andreas Buck; Volker Budach; Rebecca Bütof; Stephanie E Combs; Thorsten Derlin; Matthias Eiber; Wolfgang P Fendler; Christian Furth; Cihan Gani; Eleni Gkika; Anca-L Grosu; Christoph Henkenberens; Harun Ilhan; Steffen Löck; Simone Marnitz-Schulze; Matthias Miederer; Michael Mix; Nils H Nicolay; Maximilian Niyazi; Christoph Pöttgen; Claus M Rödel; Imke Schatka; Sarah M Schwarzenboeck; Andrei S Todica; Wolfgang Weber; Simone Wegen; Thomas Wiegel; Constantinos Zamboglou; Daniel Zips; Klaus Zöphel; Sebastian Zschaeck; Daniela Thorwarth; Esther G C Troost
Journal:  Strahlenther Onkol       Date:  2021-07-14       Impact factor: 3.621

10.  A situational awareness Bayesian network approach for accurate and credible personalized adaptive radiotherapy outcomes prediction in lung cancer patients.

Authors:  Yi Luo; Shruti Jolly; David Palma; Theodore S Lawrence; Huan-Hsin Tseng; Gilmer Valdes; Daniel McShan; Randall K Ten Haken; Issam Ei Naqa
Journal:  Phys Med       Date:  2021-06-04       Impact factor: 3.119

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.